SCI Pharmtech Inc
TWSE:4119
SCI Pharmtech Inc
Other
SCI Pharmtech Inc
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Other
NT$228k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Other
NT$26.5m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
ScinoPharm Taiwan Ltd
TWSE:1789
|
Other
NT$2.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
![]() |
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Other
-NT$312k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
81%
|
CAGR 10-Years
N/A
|
|
![]() |
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Other
-NT$188m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-66%
|
|
C
|
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
SCI Pharmtech Inc
Glance View
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
See Also
What is SCI Pharmtech Inc's Other?
Other
228k
TWD
Based on the financial report for Dec 31, 2024, SCI Pharmtech Inc's Other amounts to 228k TWD.